Influenza Vaccines: Successes and Continuing Challenges

Area of Science:

• Vaccinology
• Virology
• Immunology
• Biotechnology

Background:

• Influenza vaccines have a long history, significantly reducing disease and death.
• Current vaccine effectiveness is limited by viral evolution and egg-based production constraints.
• Egg-based production impacts global vaccine supply timelines and scalability.

Purpose of the Study:

• To explore alternative influenza vaccine design and production strategies.
• To develop next-generation vaccines offering broader and more durable immune responses.
• To enhance vaccine efficacy in immunocompromised individuals, especially the elderly.

Main Methods:

• Review of current influenza vaccine production and limitations.
• Investigation of alternative production systems, including cell culture and baculovirus expression.
• Exploration of strategies for next-generation vaccines targeting improved immunogenicity.

Main Results:

• Cell culture-based vaccines, including baculovirus systems, are now licensed.
• Next-generation vaccines aim to address antigenic drift and pandemic threats.
• Targeted approaches are being developed to boost vaccine responses in older adults.

Conclusions:

• Alternative production methods enhance vaccine scalability and timelines.
• Next-generation vaccines promise improved protection against influenza virus evolution.
• Future vaccines will focus on broader, longer-lasting immunity and specific populations.